Novartis Plans $23 Billion Investment in U.S. Facilities

Novartis announced its intention to invest $23 billion in the construction and expansion of 10 facilities across the United States last year. Bloomberg posted on X, highlighting the pharmaceutical company's strategic move to enhance its presence in the U.S. market. This investment is part of Novartis's broader plan to strengthen its manufacturing capabilities and support its growing portfolio of innovative medicines. The expansion is expected to create numerous job opportunities and contribute to the local economies where these facilities are located. Novartis's commitment to investing in the U.S. underscores its focus on meeting the increasing demand for healthcare solutions and advancing its research and development efforts.